Tag: PD-1 and PD-L1 inhibitors

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to PD-1 and PD-L1 inhibitors

Regeneron to Showcase Progress from Innovative Oncology - GlobeNewswire

Added to Collection on: 2023-10-15 22:11:08

Tags for this article:

Cancer immunotherapy
Breakthrough therapy
Lung cancer
Cemiplimab
Sanofi
Checkpoint inhibitor
Regeneron Pharmaceuticals
Non-small-cell lung cancer
Squamous-cell carcinoma
Ovarian cancer
PD-1 and PD-L1 inhibitors
Libtayo
Regeneron Pharmaceuticals Inc.

Click the tags to see associated articles and topics

View Article Details
Libtayo® (cemiplimab) Neoadjuvant Treatment Demonstrates - GlobeNewswire

Added to Collection on: 2023-10-21 18:51:50

Tags for this article:

Breakthrough therapy
Cemiplimab
Sanofi
Lung cancer
Regeneron Pharmaceuticals
Squamous-cell carcinoma
Radiation therapy
Clinical endpoint
PD-1 and PD-L1 inhibitors
Adenocarcinoma of the lung
Regeneron Pharmaceuticals Inc.

Click the tags to see associated articles and topics

View Article Details
Dr Mark Socinski Discusses the Impacts of Immunotherapy on Lung Cancer Outcomes

Added to Collection on: 2023-11-23 17:30:22

Tags for this article:

Clusters of differentiation
Cancer immunotherapy
Lung cancer
Immune system
Cancer
Cancer treatment
Immunotherapy
PD-1 and PD-L1 inhibitors
PD-L1
Programmed cell death protein 1
Cytotoxic T-lymphocyte associated protein 4
Small-cell carcinoma

Click the tags to see associated articles and topics

View Article Details
Unlocking the Potential of NK Cell Checkpoint Inhibitors in Cancer Treatment - Medriva

Added to Collection on: 2024-01-07 19:22:37

Tags for this article:

Immune system
Tumor microenvironment
Cancer immunotherapy
Immune checkpoint
Checkpoint inhibitor
Natural killer cell
Immunotherapy
Cancer treatment
Killer-cell immunoglobulin-like receptor
PD-1 and PD-L1 inhibitors
Cancer immunology
NK cells

Click the tags to see associated articles and topics

View Article Details
Rare Immune Cell May Predict Immunotherapy Response in Melanoma - Cure Today

Added to Collection on: 2024-01-07 18:56:07

Tags for this article:

Immunology
Immune system
T cells
Cancer immunotherapy
Checkpoint inhibitor
Immunotherapy
Immune checkpoint
Inflammation
Autoimmunity
PD-1 and PD-L1 inhibitors

Click the tags to see associated articles and topics

View Article Details
Merck expands cancer immunotherapy pipeline with $680m Harpoon acquisition - PMLiVE

Added to Collection on: 2024-01-11 18:17:38

Tags for this article:

Cancer immunotherapy
Bayer
Kenilworth, New Jersey
Merck & Co.
Schering-Plough
Orphan drugs
PD-1 and PD-L1 inhibitors
Roche
Atezolizumab
HARPOON THERAPEUTICS

Click the tags to see associated articles and topics

View Article Details
NICE Approves Nivolumab and Relatlimab Combination for Advanced Melanoma Treatment

Added to Collection on: 2024-01-11 16:01:31

Tags for this article:

Antineoplastic drugs
Orphan drugs
Cancer immunotherapy
Nivolumab
Immune system
Ipilimumab
Melanoma
Relatlimab
Pembrolizumab
Programmed cell death protein 1
Skin cancer
PD-1 and PD-L1 inhibitors

Click the tags to see associated articles and topics

View Article Details
Tumor biology may affect response to kidney cancer treatment, study finds - Urology Times

Added to Collection on: 2024-02-26 19:52:33

Tags for this article:

Orphan drugs
Avelumab
Sunitinib
Renal cell carcinoma
Kidney cancer
PD-1 and PD-L1 inhibitors
Cancer treatment
Axitinib

Click the tags to see associated articles and topics

View Article Details
Padcev, Keytruda, and Balversa leave little room for Opdivo in urothelial carcinoma

Added to Collection on: 2024-03-21 16:33:32

Tags for this article:

Antineoplastic drugs
Orphan drugs
Cancer immunotherapy
Cancer treatments
Carcinoma
Nivolumab
Pembrolizumab
PD-1 and PD-L1 inhibitors
Transitional cell carcinoma
Bladder cancer
Programmed cell death protein 1
Bristol-Myers Squibb

Click the tags to see associated articles and topics

View Article Details
US FDA Approval of IND for CTLA-4 Antibody YH001 for the Treatment of Front-line ...

Added to Collection on: 2024-04-07 05:49:42

Tags for this article:

Orphan drugs
Cancer immunotherapy
Biotechnology
Ipilimumab
Checkpoint inhibitor
Doxorubicin
Bispecific monoclonal antibody
Biopharmaceutical
Treatment of lung cancer
PD-1 and PD-L1 inhibitors
Biocytogen Pharmaceuticals (Beijing) Co. Ltd.
TRACON Pharmaceuticals Inc
biocytogen pharmaceuticals (beijing)

Click the tags to see associated articles and topics

View Article Details